Guangxi LiuYao Group Co., Ltd
Shanghai Stock Exchange 603368.SS
Guangxi LiuYao Group Co., Ltd EBIT for the year ending December 31, 2023: USD 152.51 M
Guangxi LiuYao Group Co., Ltd EBIT is USD 152.51 M for the year ending December 31, 2023, a 18.27% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
-
Guangxi LiuYao Group Co., Ltd EBIT for the year ending December 31, 2022 was USD 128.94 M, a 8.73% change year over year.
-
Guangxi LiuYao Group Co., Ltd EBIT for the year ending December 31, 2021 was USD 118.59 M, a -16.00% change year over year.
-
Guangxi LiuYao Group Co., Ltd EBIT for the year ending December 31, 2020 was USD 141.18 M, a -0.65% change year over year.
-
Guangxi LiuYao Group Co., Ltd EBIT for the year ending December 31, 2019 was USD 142.09 M, a 48.67% change year over year.
Key data
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Market news
Loading...
Shanghai Stock Exchange: 603368.SS
| CEO | Mr. Chaoyang Zhu |
| IPO Date | Dec. 4, 2014 |
| Location | China |
| Headquarters | No. 68, Guantang Avenue |
| Employees | 5,582 |
| Sector | Health Care |
| Industries | |
Description
Guangxi LiuYao Group Co., Ltd. engages in the distribution and retail of pharmaceutical products in China. The company was founded in 1981 and is based in Liuzhou, China. Guangxi LiuYao Group Co., Ltd is a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
Key trends
Past 5 years
Similar companies
Sinoma International Engineering Co.Ltd
USD 1.26
2.10%
China Meheco Group Co., Ltd.
USD 1.47
2.19%
Wellhope Foods Co., Ltd.
USD 1.08
1.42%
Jointown Pharmaceutical Group Co., Ltd
USD 0.67
1.67%
StockViz Staff
January 16, 2025
Any question? Send us an email